MTHFR C677T and eNOS G894T variants in preeclamptic women: Contribution to lipid peroxidation and oxidative stress

Clinical Biochemistry

Volumn 46, Issue 1-2, 2013, Pages 143-147

  Rahimi, Zohreh ^a,b   Malek Khosravi, Shohreh ^b   Rahimi, Ziba ^a   Jalilvand, Faranak ^b   Parsian, Abbas ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

ENOS G894T; Lipid peroxidation; MTHFR C677T; Preeclampsia; TAC

Indexed keywords

MALONALDEHYDE; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 84871730950     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.10.020     Document Type: Article

References (37)

1. Roten L.T., Fenstad M.H., Forsmo S., Johnson M.P., Moses E.K., Austgulen R., et al. A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 2011, 17:439-446.
2. De Maat M.P.M., Jansen M.W.J.C., Hille E.T.M., Vos H.L., Bloemenkamp K.W.M., Buitendijk S., et al. Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost 2004, 2:1588-1593.
3. Jarvenpaa J., Pakkila M., Savolainen E.R., Perheentupa A., Jarvela I., Ryynanen M. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland. Gynecol Obstet Invest 2006, 62:28-32.
4. Rahimi M., Hasanvand A., Rahimi Z., Vaisi-Raygani A., Mozafari H., Rezaei M., et al. Synergistic Effects of the MTHFR C677T and A1298C polymorphisms on the increase risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem 2010, 43:1333-1339.
5. Mello G., Parretti E., Marozio L., Pizzi C., Lojacono A., Frusca T., et al. Thrombophilia is significantly associated with severe preeclampsia results of a large-scale, case-controlled study. Hypertension 2005, 46:1270-1274.
6. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997, 34:525-526.
7. Murakami S., Matsubara N., Saitoh M., Miyakaw S., Shoji M., Kubo T. The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women. J Obstet Gynaecol Res 2001, 27:349-352.
8. Powers R.W., Dunbar M.S., Gallaher M.J., Roberts J.M. The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstet Gynecol 2003, 101:762-766.
9. Stiefel P., Miranda M.L., Bellido L.M., Luna J., Jiménez L., Pamies E., et al. Genotype of the CYBA promoter -930A/G, polymorphism C677T of the MTHFR and APOE genotype in patients with hypertensive disorders of pregnancy: an observational study. Med Clin (Barc) 2009, 133:657-661.
10. Dalmáz C.A., Santos K.G., Botton M.R., Tedoldi C.L., Roisenberg I. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population. Blood Cells Mol Dis 2006, 37:107-110.
11. O'Shaughnessy K.M., Fu B., Ferraro F., Lewis I., Downing S., Morris N.H. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 1999, 33:1338-1341.
12. Canto P., Canto-Centina T., Juarez-Velazquez R., Rosaa-Vargas H., Rangel-Villalobos H., Canizales-Quinteros S., et al. Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women. Hypertens Res 2008, 31:1015-1019.
13. Silver R.M., Zhao Y., Spong C.Y., Sibai B., Wendel G., Wenstrom K. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010, 115:14-20.
14. Serrano N.C., Casas J.P., DíD́az L.A., PaD́ez C., Mesa C.M., Cifuentes R., et al. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension 2004, 44:702-707.
15. Sharma D., Singh A., Trivedi S.S., Bhattacharjee J. Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: a pilot study in a North Indian population. Hum Immunol 2011, 72:436-439.
16. Ozturk E., Balat O., Pehlivan S., Ugur M.G., Ozcan C., Sever T., et al. Endothelial nitric oxide synthase gene polymorphisms in preeclampsia with or without eclampsia in a Turkish population. J Obstet Gynaecol Res. 2011, 37:1778-1783.
17. Hakli T., Romppanen E.L., Hiltunen M., Helisalmi S., Punnonen K., Heinonen S. Endothelial nitric oxide synthase polymorphism in preeclampsia. J Soc Gynecol Investig 2003, 10:154-157.
18. Yoshimura T., Chowdhury F.A., Yoshimura M., Okamura H. Genetic and environmental contributions to severe preeclampsia: lack of association with the endothelial nitric oxide synthase Glu298Asp variant in developing country. Gynecol Obstet Invest 2003, 56:10-13.
19. Landau R., Xie H.G., Dishy V., Wood A.J., Stein C.M., Smiley R.M. No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia. Am J Hypertens 2004, 17:391-394.
20. Singh A., Sharma D., Raghunandan C., Bhattacharjee J. Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of pre-eclampsia. Am J Reprod Immunol 2010, 63:244-251.
21. Yu C.K., Casas J.P., Savvidou M.D., Sahemey M.K., Nicolaides K.H., Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. BMC Pregnancy Childbirth 2006, 6:7.
22. Sandrim V.C., Palei A.C.T., Sertorio J.T., Cavalli R.C., Duarte G., Tanus-Santos J.E. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Mol Hum Reprod 2010, 16:506-510.
23. Shaik A.P., Sultana A., Bammidi V.K., Sampathirao K., Jamil K. A meta-analysis of eNOS and ACE gene polymorphisms and risk of pre-eclampsia in women. J Obstet Gynaecol 2011, 31:603-607.
24. Chen L.K., Huang C.H., Yeh H.M., Lee C.N., Shyu M.K., Hsieh F.J., et al. Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population. Reprod Sci 2007, 14:175-181.
25. Jafari Y., Rahimi Z., Vaisi-Raygani A., Rezaei M. Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem 2011, 353:23-34.
26. Hingorani A.D. Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep 2003, 5:19-25.
27. Malek-Khosravi Sh., Rahimi Z., Rahimi Z., Jalilvand F., Parsian A. Thrombophilic mutations and susceptibility to preeclapmsia in western Iran. J Thromb Thrombolysis 2012, 33:109-115.
28. Rahimi Z., Muniz A., Parsian A. Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques. Mol Biol Rep 2010, 37:149-154.
29. Rahimi Z., Vaisi-Raygani A., Rahimi Z., Parsian A. The concomitant presence of eNOS 894T and ACE D alleles are associated with diabetic nephropathy in Kurdish population from western Iran. Nephrology 2012, 17:175-181.
30. Agarwal R. Rapid fluorimetric-liquid chromatographic determination of malodialdehyde in biological samples. J Chromatogr B 2002, 775:121-126.
31. Nurk E., Tell G.S., Refsum H., Ueland P.M., Vollset S.E. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. Q J Med 2006, 99:289-298.
32. Makkonen N., Heinonen S., Hiltunen M. Apolipoprotein E, alleles in women with pre-eclampsia. J Clin Pathol 2001, 54:652-654.
33. Patil S.B., Kodliwadmath M.V., Kodliwadmath M. Lipid peroxidation and antioxidant activity in complicated pregnancies. Clin Exp Obstet Gynecol 2009, 36:110-112.
34. Aris Kharfi A., Leblanc S., Ouellet A., Moutquin J.M. Dual action of H2O2 on placental hCG secretion: implications for oxidative stress in preeclampsia. Clin Biochem 2007, 40:94-97.
35. Yilmaz H., Agachan B., Isbir T., Akoglu E. Is there additional effect of MTHFR C677T mutation on lipid abnormalities in renal allograft recipients?. Transplant Proc 2003, 35:1390-1392.
36. Ventura P., Panini R., Verlato C., Scarpetta G., Salvioli G. Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading. Metabolism 2000, 49:225-228.
37. Sharma D., Trivedi S.S., Bhattacharjee J. Oxidative stress and eNOS (Glu298Asp) gene polymorphism in preeclampsia in Indian population. Mol Cell Biochem 2011, 353:189-193.